Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
PHG logo PHG
Upturn stock ratingUpturn stock rating
PHG logo

Koninklijke Philips NV ADR (PHG)

Upturn stock ratingUpturn stock rating
$28.17
Last Close (24-hour delay)
Profit since last BUY14.23%
upturn advisory
Consider higher Upturn Star rating
BUY since 47 days
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

09/15/2025: PHG (1-star) has a low Upturn Star Rating. Not recommended to BUY.

Upturn Star Rating

rating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

Number of Analysts

rating

3 Analysts rated it

Very few follow this stock; limited insights, higher-risk early investing.

1 Year Target Price $32.77

1 Year Target Price $32.77

Analysts Price Target For last 52 week
$32.77 Target price
52w Low $20.65
Current$28.17
52w High $31.64

Analysis of Past Performance

Type Stock
Historic Profit 2.05%
Avg. Invested days 36
Today’s Advisory Consider higher Upturn Star rating
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 2.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 09/15/2025

Key Highlights

Company Size Large-Cap Stock
Market Capitalization 26.98B USD
Price to earnings Ratio 148.42
1Y Target Price 32.77
Price to earnings Ratio 148.42
1Y Target Price 32.77
Volume (30-day avg) 3
Beta 0.83
52 Weeks Range 20.65 - 31.64
Updated Date 09/15/2025
52 Weeks Range 20.65 - 31.64
Updated Date 09/15/2025
Dividends yield (FY) 3.43%
Basic EPS (TTM) 0.19

Analyzing Revenue: Products, Geography and Growth

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin 0.91%
Operating Margin (TTM) 9.24%

Management Effectiveness

Return on Assets (TTM) 2.37%
Return on Equity (TTM) 1.51%

Valuation

Trailing PE 148.42
Forward PE 14.79
Enterprise Value 34559937570
Price to Sales(TTM) 1.51
Enterprise Value 34559937570
Price to Sales(TTM) 1.51
Enterprise Value to Revenue 1.65
Enterprise Value to EBITDA 12.21
Shares Outstanding 950574016
Shares Floating 767446306
Shares Outstanding 950574016
Shares Floating 767446306
Percent Insiders -
Percent Institutions 5.42

ai summary icon Upturn AI SWOT

Koninklijke Philips NV ADR

stock logo

Company Overview

overview logo History and Background

Koninklijke Philips NV was founded in 1891 in Eindhoven, Netherlands. Initially focused on manufacturing light bulbs, Philips has evolved into a diversified technology company with interests in healthcare, personal health, and connected care. Key milestones include the introduction of the Philishave electric shaver in 1939, expansion into medical equipment in the 20th century, and a recent shift towards health technology solutions.

business area logo Core Business Areas

  • Diagnosis & Treatment: Develops and markets medical imaging systems, image-guided therapy solutions, and healthcare informatics. Products include MRI, CT scanners, ultrasound systems, and interventional X-ray systems.
  • Connected Care: Offers patient monitoring solutions, telehealth platforms, and hospital management systems designed to improve patient outcomes and efficiency. Includes products for sleep and respiratory care, and personal emergency response systems.
  • Personal Health: Focuses on consumer health products, including oral healthcare, mother and child care, male grooming, and beauty devices. Main products are Sonicare electric toothbrushes and Avent baby products.

leadership logo Leadership and Structure

The CEO of Koninklijke Philips NV is Roy Jakobs. The company operates with a divisional structure aligned with its core business areas. The board of directors oversees the executive management team.

Top Products and Market Share

overview logo Key Offerings

  • Magnetic Resonance Imaging (MRI) Systems: Philips provides advanced MRI systems used for diagnostic imaging. Competitors include GE Healthcare (GE), Siemens Healthineers (SIEGY), and Canon Medical Systems. Market share varies by region but typically ranks among the top three globally. Revenue is a major portion of their diagnostic treatment revenue. Not possible to provide a specific number.
  • Computed Tomography (CT) Scanners: Philips offers CT scanners used for a wide range of medical applications. Major competitors are GE Healthcare (GE), Siemens Healthineers (SIEGY), and Canon Medical Systems. Market share varies by region and modality; similar to MRI, usually in the top 3 in the world. Revenue is a major portion of their diagnostic treatment revenue. Not possible to provide a specific number.
  • Sonicare Electric Toothbrushes: Philips Sonicare is a leading brand of electric toothbrushes focused on premium oral healthcare. Competitors include Oral-B (PG) and Colgate (CL). Sonicare has a significant market share in the electric toothbrush market.
  • Patient Monitoring Systems: Philips offers a wide range of patient monitoring solutions used in hospitals and other healthcare settings. Competitors include Medtronic (MDT), Masimo (MASI) and GE Healthcare (GE). Philips holds a significant market share.

Market Dynamics

industry overview logo Industry Overview

The healthcare technology industry is experiencing growth due to aging populations, increasing prevalence of chronic diseases, and technological advancements. The personal health segment is driven by consumer interest in wellness and preventative care. Increasing regulation and cybersecurity threats are key concerns.

Positioning

Philips is positioning itself as a leader in health technology, emphasizing integrated solutions and data-driven insights. Its competitive advantages include a strong brand reputation, a broad product portfolio, and a global presence.

Total Addressable Market (TAM)

The global healthcare technology market is expected to reach hundreds of billions of dollars. Philips is well-positioned to capture a significant portion of this TAM through its diverse portfolio.

Upturn SWOT Analysis

Strengths

  • Strong brand recognition
  • Diversified product portfolio
  • Global presence
  • Innovation in health technology
  • Established distribution network

Weaknesses

  • Past product recalls have damaged reputation
  • Complex organizational structure
  • Exposure to regulatory risks
  • Dependence on healthcare spending

Opportunities

  • Growth in emerging markets
  • Expansion of telehealth services
  • Increased adoption of AI and data analytics
  • Strategic acquisitions
  • Growing demand for personalized healthcare

Threats

  • Intense competition
  • Technological obsolescence
  • Changes in healthcare regulations
  • Economic downturns
  • Cybersecurity threats

Competitors and Market Share

competitor logo Key Competitors

  • GE
  • SIEGY
  • MDT
  • PG
  • CL

Competitive Landscape

Philips' faces competition from various players in its different business segments. Its advantages include a strong brand and a diversified portfolio. Disadvantages may include higher cost structure in some areas.

Major Acquisitions

Spectranetics

  • Year: 2017
  • Acquisition Price (USD millions): 2200
  • Strategic Rationale: To expand Philips' image-guided therapy portfolio.

Growth Trajectory and Initiatives

Historical Growth: Philips' growth has been influenced by economic conditions, industry trends, and strategic decisions. Refer to Philips' financial reports for historical growth data.

Future Projections: Analyst projections for Philips' future growth are available from financial analysts. Please review analyst reports.

Recent Initiatives: Recent initiatives include expanding its presence in emerging markets, focusing on health technology solutions, and streamlining its business operations.

Summary

Koninklijke Philips NV is a large global conglomerate in the healthcare technology space with a strong brand presence. Its shift towards healthcare is promising, given the increasing demand for medical equipment and services. However, the company needs to address product recalls and operational efficiency. Competition remains a key challenge for Koninklijke Philips NV, as does the need to stay ahead of technological advancements and regulatory changes.

Peer Comparison

Sources and Disclaimers

Data Sources:

  • Company Filings
  • Financial News Outlets
  • Market Research Reports
  • Analyst Reports

Disclaimers:

This analysis is for informational purposes only and does not constitute financial advice. Investment decisions should be based on individual research and consultation with a qualified financial advisor. Market data and financial figures are subject to change.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Koninklijke Philips NV ADR

Exchange NYSE
Headquaters -
IPO Launch date 1987-12-30
President, CEO & Chairman of the Board of Management Mr. Roy Jakobs
Sector Healthcare
Industry Medical Devices
Full time employees 67263
Full time employees 67263

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment, Connected Care, and Personal Health segments. It provides diagnostic imaging solutions, includes magnetic resonance imaging; X-ray systems; and computed tomography (CT) systems and software comprising detector-based spectral CT solutions; ultrasound imaging solutions focused on diagnosis, treatment planning and guidance for cardiac, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional X-ray systems and software solutions; and interventional image devices and software to aid in the diagnosis, navigation, treatment, and confirmation in minimally invasive interventional coronary, peripheral vascular, and hearth rhythm management procedures. The company also offers acute patient management solutions; emergency care solutions; patient care management in ambulatory and home care; sleep and respiratory care solutions; and vendor-agnostic software solutions. In addition, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental and women's health solutions; and grooming and beauty products and solutions. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.